TY - JOUR
T1 - Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials
AU - Daniele, Gennaro
AU - Arenare, Laura
AU - Scambia, Giovanni
AU - Pisano, Carmela
AU - Sorio, Roberto
AU - Breda, Enrico
AU - De Placido, Sabino
AU - Savarese, Antonella
AU - Ferrandina, Gabriella
AU - Raspagliesi, Francesco
AU - Panici, Pierluigi Benedetti
AU - Ferro, Antonella
AU - Rimanti, Anita
AU - Cormio, Gennaro
AU - Lorusso, Domenica
AU - Cecere, Sabrina Chiara
AU - Scalone, Simona
AU - Marsico, Valentina Angela
AU - Cardalesi, Cinzia
AU - Cognetti, Francesco
AU - Salutari, Vanda
AU - Attademo, Laura
AU - Guizzaro, Lorenzo
AU - Schettino, Clorinda
AU - Piccirillo, Maria Carmela
AU - Perrone, Francesco
AU - Gallo, Ciro
AU - Pignata, Sandro
PY - 2019/7
Y1 - 2019/7
N2 - Chemotherapy-induced neutropenia (CIN) has been associated with improved prognosis in several cancer conditions. Contrasting data have been produced in ovarian cancer.
AB - Chemotherapy-induced neutropenia (CIN) has been associated with improved prognosis in several cancer conditions. Contrasting data have been produced in ovarian cancer.
KW - Chemotherapy-induced neutropenia
KW - Cytotoxic dosing methods
KW - Meta-analysis
KW - Ovarian cancer
KW - Prognostic factors
KW - Retrospective-prospective design
KW - Antineoplastic Combined Chemotherapy Protocols/adverse effects/therapeutic use
KW - Carboplatin/administration & dosage/adverse effects
KW - Doxorubicin/administration & dosage/adverse effects/analogs & derivatives
KW - Female
KW - Humans
KW - Kaplan-Meier Estimate
KW - Middle Aged
KW - Neoplasm Staging
KW - Neutropenia/chemically induced
KW - Ovarian Neoplasms/blood/drug therapy/pathology
KW - Paclitaxel/administration & dosage/adverse effects
KW - Polyethylene Glycols/administration & dosage/adverse effects
KW - Prognosis
KW - Progression-Free Survival
KW - Prospective Studies
KW - Retrospective Studies
U2 - 10.1016/j.ygyno.2019.04.012
DO - 10.1016/j.ygyno.2019.04.012
M3 - Article
VL - 154
SP - 83
EP - 88
JO - Gynecologic Oncology
JF - Gynecologic Oncology
SN - 0090-8258
IS - 1
ER -